Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Johnson & Johnson buy Cowen Inc

Start price
€164.40
14.10.25 / 50%
Target price
-
14.10.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.10.26. The prediction end date can be changed by Cowen_Inc at any time.

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w
Johnson & Johnson -
iShares Core DAX® -0.446%
iShares Nasdaq 100 -0.671%
iShares Nikkei 225® -1.289%
iShares S&P 500 -0.662%

Comments by Cowen_Inc for this prediction

In the thread Johnson & Johnson diskutieren

Johnson & Johnson (NYSE:JNJ) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for JNJ provided by MarketBeat